Hellenic Cooperative Oncology Group
Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis
2010 · Wendy De Roock, Bart Claes, et al. · The Lancet Oncology
Atezolizumab, Bevacizumab, and Chemotherapy for Newly Diagnosed Stage III or IV Ovarian Cancer: Placebo-Controlled Randomized Phase III Trial (IMagyn050/GOG 3015/ENGOT-OV39)
2021 · Kathleen N. Moore, Michael A. Bookman, et al. · Journal of Clinical Oncology
Randomized comparison of etoposide-cisplatin vs. etoposide-carboplatin and irradiation in small-cell lung cancer
1994 · D. Skarlos, E. Samantas, et al. · Annals of Oncology